Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Regorafenib Assessment in Refractory Advanced Colorectal Cancer(RegARd-C) (RegARd-C)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01929616
Recruitment Status : Completed
First Posted : August 28, 2013
Last Update Posted : June 25, 2019
Information provided by (Responsible Party):
Jules Bordet Institute